- Home
- PLBY vs LVTX Comparison
PLBY vs LVTX Comparison
Compare PLBY & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- LVTX
- Stock Information
- Founded
- PLBY 1953
- LVTX 2016
- Country
- PLBY United States
- LVTX Netherlands
- Employees
- PLBY N/A
- LVTX N/A
- Industry
- PLBY Recreational Games/Products/Toys
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- LVTX Health Care
- Exchange
- PLBY Nasdaq
- LVTX Nasdaq
- Market Cap
- PLBY 187.1M
- LVTX 41.3M
- IPO Year
- PLBY N/A
- LVTX 2021
- Fundamental
- Price
- PLBY $1.54
- LVTX $1.54
- Analyst Decision
- PLBY Strong Buy
- LVTX Hold
- Analyst Count
- PLBY 1
- LVTX 4
- Target Price
- PLBY $3.00
- LVTX $1.58
- AVG Volume (30 Days)
- PLBY 315.0K
- LVTX 111.8K
- Earning Date
- PLBY 11-11-2025
- LVTX 08-13-2025
- Dividend Yield
- PLBY N/A
- LVTX N/A
- EPS Growth
- PLBY N/A
- LVTX N/A
- EPS
- PLBY N/A
- LVTX N/A
- Revenue
- PLBY $119,954,000.00
- LVTX $4,990,000.00
- Revenue This Year
- PLBY $6.32
- LVTX N/A
- Revenue Next Year
- PLBY $3.49
- LVTX N/A
- P/E Ratio
- PLBY N/A
- LVTX N/A
- Revenue Growth
- PLBY N/A
- LVTX N/A
- 52 Week Low
- PLBY $0.56
- LVTX $0.85
- 52 Week High
- PLBY $2.44
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- PLBY 38.30
- LVTX 51.06
- Support Level
- PLBY $1.63
- LVTX $1.53
- Resistance Level
- PLBY $1.84
- LVTX $1.58
- Average True Range (ATR)
- PLBY 0.10
- LVTX 0.03
- MACD
- PLBY -0.01
- LVTX -0.01
- Stochastic Oscillator
- PLBY 3.49
- LVTX 35.71
About PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.